01950nam a2200433 4500 7701 9291681687 7701 20050111d2004 y0pory50 ba eng Hepatitis C and injecting drug use impact, costs and policy options European Monitoring Centre for Drugs and Drug Addiction ed. lit. Johannes Jager, Wien Limburg ... [et all.] Luxembourg Office for Official Publications of the European Communities 2004 389 p. 24 cm EMCDDA - Scientific Monograph Series 7 Part I - Natural history, treatment, quality of life, epidemiology and prevention. Part II - Models of hepatitis C, injecting drug use and policy options. Part III - Healthcare costs of drug-related hepatitis C infection. Part IV - Wider costs of drug use. Part V - Cost-effectiveness of needle and syringe programmes and methadone maintenance. SAÚDE PÚBLICA 1370 TRATAMENTO DE TOXICODEPENDENTE 104400 METADONA 102402 CONSUMO DE DROGA 5102 PREVENÇÃO PRIMÁRIA 5157 POLÍTICA SOCIAL 1220 HEPATITE 104401 HIV 945 PROGRAMAS DE TRATAMENTO 8719 UNIÃO EUROPEIA 100 Jager Jager 340 8720 Limburg Wien 340 104402 Kretzschmar Mirjam 340 104403 Postma Maarten 340 104404 Wiessing Lucas 340 104405 EUROPEAN MONITORING CENTER FOR DRUGS AND DRUG ADDICTION - EMCDDA 8685 DRO227 0 DRO_227_000000000000000 2021-12-17 4679 10503 DGRSP DGRSP DGRSP4679583954 DRO227 2021-12-17 0 MO oferta